Kirkland Represents TJC on Acquisition of Majority Stake of Delrin
Kirkland & Ellis represented private equity firm TJC on its acquisition of an 80.1% stake of resins unit Delrin from chemical company DuPont in a transaction that values the business at $1.8 billion. The deal was announced August 21, 2023 and is expected to close around the end of 2023. At the close of the deal, DuPont will receive $1.25 billion in cash and a note receivable of $350 million.
The Kirkland team was led by corporate partners Andrew Arons and Michael Amalfe and associates Oliver Yee, Deborah Kotkin and Molly Kaleya; debt finance partners Jason Kanner and Andrea Weintraub and associates Conor O’Muiri and Brian Caldwell; tax partners Jared Rusman and Sherry Xie and associate Leah Blake; technology and IP transactions partner Adam Petravicius and associate Rob Patrignani; environmental partners Sara Michaelchuck Webber and Emily Tabak and associates Caitlin Meagher and Katherine McKeen; employee & labor partners R.D. Kohut and Mari Stonebraker and associates Jackson Phinney and Kaitlyn Hodgman; executive compensation partner Michael Krasnovsky and associates Karsten Busby and Michal Galayevich; employee benefits partner Matthew Antinossi and associate Jack Amaro; real estate partner Lanre Williams and associate Gina Garcia and Michael Kenneally; international trade & national security partners Daniel Gerkin and Nick Niles and associate Brad Dumbacher; antitrust & competition partners Peter McCormack, Paula Riedel, Philipp Gnatzy and Shahrzad Sadjadi and associates Chris Salvatore and Juan Donado-Diez.
